Valuation

TEVATeva Pharmaceutical Industries Limited

StockNYSE以色列Health careEU retail: available

−2.0% today · +107.2% over a year

6/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 61% of the instruments we score

Trend, Stability: among the best of its peers. No dividend.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricTEVASector medianvs median
P/E65.022.4 · n=22190% above
P/B5.93.6 · n=3962% above
P/S2.74.5 · n=3441% below
EV/EBIT36.821.8 · n=2268% above
Free-cash-flow yield2.9%2.2% · n=3734% above
Dividend yield0.00%0.13% · n=100100% below
Return on equity9.7%4.2% · n=50132% above
Return on invested capital7.4%6.5% · n=4114% above
Gross margin52.5%70.5% · n=3326% below
Net debt / EBITDA5.011.39 · n=22260% above

Value factor: 56 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
NOVNNovartis AG21.26.417.85.9%2.9%10/10
NVSNovartis AG20.66.317.36.1%3.2%10/10
AZNAstraZeneca PLC26.05.521.14.4%1.3%6/10
NVONovo Nordisk A/S11.36.09.95.1%4.7%8/10
SNYSanofi11.61.316.08.0%5.0%7/10
SANSanofi SA11.61.315.98.0%5.6%9/10
ALCAlcon AG35.01.627.55.0%0.5%5/10
ALCAlcon34.91.627.55.1%0.5%5/10
ROIVRoivant Sciences Ltd.—6.2—−2.9%0.0%1/10
STESTERIS28.13.121.14.1%0.8%8/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 6月 2026 · filed 29 7月 2026